Considering the age-related and low and penetrance of LRRK2 G20109S mutation [1, 2], it is possible that we have studied subjects who will never develop PD or at a very early phase of the disease when biochemical and pathological events have not yet started [10]. The gene discussed is LRRK2; the disease is Parkinson disease.